Sep 04, 2014 01:51 PM EDT
New Hope For Patients with Chronic Lymphocytic Leukemia
Researchers at the University of California, San Diego School of Medicine in partnership with the California Institute for Regenerative Medicine (CIRM) and Celgene Corporation, have just launched a phase 1 human clinical trial to better assess the safety and efficacy of a novel monoclonal antibody f...